Thermo Fisher Scientific | TMO - Assets


Thermo Fisher Scientific reported $113.28B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 9.79B 786.5M Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
General Electric Aerospace USD 127.67B 773M Jun/2026
Henry Schein USD 11.3B 89M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Laboratory Of America USD 19.09B 694.4M Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
Olympus JPY 1.54T 79.24B Mar/2026
OraSure Technologies USD 379.17M 24M Mar/2026
Quest Diagnostics USD 16.67B 448M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Veracyte USD 1.44B 30.38M Mar/2026
Waters USD 24.53B 19.45B Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026